We have not found any cost information for this lawyer
The Chambers USA Guide to America’s Leading Lawyers describes Howard as "a tireless advocate for his clients" who "impresses with his superb analytical and communications skills" and as "valued for his practical experience as a former Assistant Director of the FTC Bureau of Competition."
5
Practice Areas
40 years | 100 cases
28 years | 5 cases
32 years | 20 cases
38 years | 100 cases
We have not found any cost information for this lawyer
Quickly connect with top attorneys through our legal directory to get help with your legal issue.
Chat with a live agent who can match you with the right attorney for your legal needs.
Chat withState: District of Columbia
Acquired: 1984
No misconduct found
777 6th Street, N.W., Washington, DC, 20001-3723
Not Yet Reviewed
No Endorsement Data Available Yet
This attorney hasn't received any attorney endorsements recently on Avvo.
No Endorsement Data Available Yet
This attorney hasn't created any attorney endorsements recently on Avvo.
2011
America’s Leading Lawyers for Business, Chambers USA:
2008
Guide to the World’s Leading Lawyers, Legal Media Group
2007
SuperLawyer, Washington, D.C. Super Lawyers
1997
Award for Superior Service, Federal Trade Commission Commission
2010 - Present
Partner, Cooley LLP
1998 - 2010
Partner and Chair of Antitrust Practice Group, Drinker Biddle & Reath LLP
1988 - 1997
Assistant Director, Bureau of Competition, Federal Trade Commission
2009 - Present
American Bar Association, Section of Antitrust Law, Federal Civil Enforcement CommitteeChair
2004 - 2007
Intellectual Property Owners Association, Antitrust & Competition Law CommitteeVice-Chair
1997 - 2009
American Bar Association, Section of Antitrust Law, Computer, Intellectual Property and Exemptions & Immunities CommitteesChair
Motion to Dismiss Granted
Motion to dismiss antitrust counterclaim denied
1984
J.D., cum laude
1981
A.B., summa cum laude
2011
2010
Enforcement Priorities of the Obama Administration: What is Happening at the DOJ and FTC
2009
2008
2008
Assessing What the Authorized Generic Drug Study and Report on Intellectual Property Collectively Mean for the Pharmaceutical Industry
2011
2010
2010
2009
2009
2006
2005
2004
2003
2002
2002
2001
1998
English